Hospital News and Research

RSS

Review highlights TIGIT as a promising second-generation immunotherapy target

Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.

5 Jun 2026

EULAR Congress highlights innovative support strategies for rheumatology patients

Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.

5 Jun 2026

Fatherhood linked to lower mortality risk among Black men

Fatherhood in Black men is associated with lower rates of all-cause mortality by middle age compared to nonfathers, according to the U.S.-based longitudinal study that enrolled Black and White individuals aged 18-30 years at baseline (1985-86).

4 Jun 2026

NWSL and American Heart Association expand CPR awareness efforts

To raise awareness of CPR, the American Heart Association, a relentless force changing the future of health for everyone everywhere, and the National Women's Soccer League (NWSL) today unveiled the 2026 Nation of Lifesavers NWSL Ambassador Class during National CPR and AED Awareness Week, held annually from June 1-7.

4 Jun 2026

Common hypertension drugs tied to worse kidney outcomes in T2D patients

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already receiving modern kidney-protective treatments.

4 Jun 2026

Universal Sarbeco coronavirus vaccine proves safe in first human trial

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects.

4 Jun 2026

Repurposed cancer therapy enables successful kidney transplantation

A pioneering clinical trial has successfully enabled three patients with end-stage kidney disease to receive previously improbable kidney transplants.

4 Jun 2026

Seven-second X-ray scan detects severe pulmonary valve regurgitation with high accuracy

Researchers at Kyushu University have developed a simple, rapid, and low-radiation X-ray technique that can evaluate the severity of a heart condition known as pulmonary valve regurgitation-a common and clinically significant complication after surgical repair of a congenital heart defect known as Tetralogy of Fallot.

4 Jun 2026

Teen insomnia symptoms linked to hospitalizations in young adulthood

A new study to be presented at the SLEEP 2026 annual meeting found that poorer sleep health according to wrist actigraphy and insomnia symptoms during adolescence predicted a higher likelihood of an overnight hospital stay during young adulthood around seven years later, even after accounting for adolescent hospitalizations and sleep health.

4 Jun 2026

Pulse-wave tracking at home catches spontaneous normal heart rhythms early

Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant healthcare resources ahead of planned electrical cardioversion in patients with atrial fibrillation. This is shown in a new study published in JAMA Cardiology by researchers at Karolinska Institutet and Danderyd Hospital.

4 Jun 2026

Real-world study exposes suboptimal adherence to treat-to-target rheumatic strategies

EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to complement knowledge from randomized controlled trials.

4 Jun 2026

New data confirms dengue vaccine safety for older and chronic-risk travelers

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.

4 Jun 2026

New all-oral regimen improves treatment convenience for AML patients

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.

3 Jun 2026

Novel CAR T treatment makes previously impossible kidney transplants possible

A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously improbable kidney transplants.

3 Jun 2026

Patented technology enables real-time detection of surgical bleeding sources

The United States Patent and Trademark Office (USPTO) officially issued a new patent to Wayne State University and RediMinds Inc. of Southfield, Michigan. The patent protects a pioneering technological advancement developed in the university's laboratories.

3 Jun 2026

Study links rural living to worse epilepsy health outcomes

For people with epilepsy, living in counties that are more rural was associated with poorer health outcomes than for people living in more urban counties, according to a study published June 3, 2026, in Neurology, the medical journal of the American Academy of Neurology.

3 Jun 2026

Air pollution below EPA thresholds still poses heart health risks

Air pollution does not have to exceed federal limits to potentially harm human health, according to a new review published in Environmental Pollution.

3 Jun 2026

Study potentially opens a new route to more selective cancer drug design

Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise cancer drugs.

3 Jun 2026

New manufacturing platform produces targeted mixtures of beneficial gut bacteria

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for patients with recurrent Clostridioides difficile (C. difficile) infection.

3 Jun 2026